Published in J Clin Microbiol on December 01, 1975
Yersinia enterocolitica: the charisma continues. Clin Microbiol Rev (1997) 4.70
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13
Development of a two-step enrichment procedure for recovery of Yersinia enterocolitica from food. Appl Environ Microbiol (1982) 1.93
Yersinia enterocolitica isolates from humans in California, 1968-1975. J Clin Microbiol (1976) 1.91
Yersinia enterocolitica in adults with gastrointestinal disturbances: need for cold enrichment. J Clin Microbiol (1980) 1.82
Long-term fecal excretion and resistance induced in mice infected with Yersinia enterocolitica. Infect Immun (1978) 1.47
Isolation of virulent Yersinia enterocolitica from porcine tongues. Appl Environ Microbiol (1981) 1.33
Comparative study of selective media for recovery of Yersinia enterocolitica. J Clin Microbiol (1982) 1.28
Rapid isolation of Yersinia spp. from feces. J Clin Microbiol (1982) 1.24
Yersinia enterocolitica: recovery and characterization of two unusual isolates from a case of acute enteritis. J Clin Microbiol (1977) 1.22
Identification of Yersinia spp. with the API 20E system. J Clin Microbiol (1987) 1.15
Current trends of Yersinia enterocolitica isolates in the New York City area. J Clin Microbiol (1983) 1.14
Yersinia pseudotuberculosis: use of cold-temperature enrichment for isolation. J Clin Microbiol (1980) 1.13
Identification and characterization of Yersinia intermedia isolated from human feces. J Clin Microbiol (1987) 0.96
Yersinia enterocolitica: serotypes and biotypes isolated from humans and the environment in Quebec, Canada. J Clin Microbiol (1978) 0.94
Lack of efficacy of alkali treatment for isolation of Yersinia enterocolitica from feces. J Clin Microbiol (1983) 0.92
Faecal carriage rate of Yersinia species. J Hyg (Lond) (1986) 0.91
Differential and selective medium for isolation of Yersinia enterocolitica from stools. J Clin Microbiol (1982) 0.86
Detection of Yersinia enterocolitica in food: an overview. Eur J Clin Microbiol Infect Dis (2014) 0.85
Yersinia pseudotuberculosis infection: study of an epizootic in squirrel monkeys. J Clin Microbiol (1981) 0.84
Current evidence for human yersiniosis in Ireland. Eur J Clin Microbiol Infect Dis (2012) 0.76
Acute Enteritis in Guinea Pigs Due to Yersinia enterocolitica. Can Vet J (1983) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Generalized Yersinia enterocolitica infection. J Infect Dis (1975) 3.55
Yersinia enterocolitica. N Engl J Med (1970) 2.34
The first successful isolations and identification of Yersinia enterocolitica from human cases in Japan. Jpn J Microbiol (1972) 2.10
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28
Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10
Clinical utility of thoracoscopy. Chest (1992) 6.34
Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol (1970) 5.61
Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45
Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27
Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22
Characterization of saccharolytic nonfermentative bacteria associated with man. Can J Microbiol (1970) 5.07
Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79
Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28
Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60
Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54
Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52
Rapid method for identification of gram-negative, nonfermentative bacilli. J Clin Microbiol (1976) 3.24
Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16
Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14
Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11
Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09
Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89
Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87
Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86
Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85
In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82
Nonfermentative bacilli associated with man. II. Detection and identification. Am J Clin Pathol (1970) 2.69
Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60
API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54
Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53
Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51
Salient features of nonsaccharolytic and weakly saccharolytic nonfermentative rods. Can J Microbiol (1970) 2.50
Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50
Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48
Diverticula of the Small Bowel. Ann Surg (1934) 2.44
Salient features of Haemophilus vaginalis. J Clin Microbiol (1979) 2.40
Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37
Bacteroides bacteremia. Minn Med (1970) 2.36
Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26
Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26
Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23
Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12
Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12
Molecular techniques for the detection of Chlamydia trachomatis. J Clin Microbiol (1989) 2.10
Recovery of Yersinia enterocolitica from streams and lakes of California. Appl Environ Microbiol (1976) 2.08
Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res (1988) 2.06
Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05
Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04
Detection, identification, and comparison of Capnocytophaga, Bacteroides ochraceus, and DF-1. J Clin Microbiol (1979) 2.02
Probable Campylobacter fetus subsp. fetus gastroenteritis. J Clin Microbiol (1983) 1.99
Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97
Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94
Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med (1970) 1.90
Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90
Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87
Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res (1991) 1.86
Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83
Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80
In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc (1970) 1.72
Cell-adhesive motif in region II of malarial circumsporozoite protein. Science (1990) 1.69
An analgesia circuit activated by cannabinoids. Nature (1998) 1.68
Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67
An outbreak of chancroid in Orange County, California: descriptive epidemiology and disease-control measures. J Infect Dis (1985) 1.65
Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63
In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60
Nonfermentative bacilli associated with man. I. Nomenclature. Am J Clin Pathol (1970) 1.57
Methods for distinguishing gram-positive from gram-negative bacteria. J Clin Microbiol (1982) 1.57
Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A (1971) 1.55
120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53
Experimental Cholera in Chinchillas: the Immune Response in Serum and Intestinal Secretions to Vibrio cholerae and Cholera Toxin. Infect Immun (1974) 1.53
Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53
In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53
Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. Am J Clin Pathol (1974) 1.52
Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc (1972) 1.52
Isolation of Brucella spp. from clinical specimens. J Clin Microbiol (1984) 1.52
Site of action of antilymphocyte globulin. Lancet (1967) 1.51
Identification of oxidase-positive, glucose-negative, motile species of nonfermentative bacilli. J Clin Microbiol (1986) 1.51
Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis (1984) 1.50
Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50
Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother (1981) 1.49
Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest (1988) 1.48
Interaction of vitronectin with Pneumocystis carinii: evidence for binding via the heparin binding domain. J Lab Clin Med (1995) 1.48
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
Oxidant injury of lung parenchymal cells. J Clin Invest (1981) 1.44
Recent Trends of Some Infectious Diseases. Br Med J (1942) 1.44
Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44
Simplified method of anaerobic incubation. Appl Microbiol (1971) 1.44
Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med (1996) 1.41
Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum (1988) 1.41
Comparison of the Minitek test system with a conventional screening procedure for identification of Enterobacteriaceae. Health Lab Sci (1978) 1.40
Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol (1989) 1.40
Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes. Nat New Biol (1971) 1.38
Experimental cholera in the chinchilla. J Infect Dis (1974) 1.38